PTK6 activation at the membrane regulates epithelial-mesenchymal transition in prostate cancer.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cancer Research

• Publication date

  2013-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-13-0443PMID 23856248PMCID PMC3766391
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Context‐specific protein tyrosine kinase 6 (PTK6) signalling in prostate cancer

  2013cited by this paper
• Mechanisms that link the oncogenic epithelial–mesenchymal transition to suppression of anoikis

  2013cited by this paper
• Brk/PTK6 cooperates with HER2 and Src in regulating breast cancer cell survival and epithelial-to-mesenchymal transition

  2013cited by this paper
• The Epithelial-Mesenchymal Transition (EMT) Regulatory Factor SLUG (SNAI2) Is a Downstream Target of SPARC and AKT in Promoting Melanoma Cell Invasion

  2012cited by this paper
• Protein Tyrosine Kinase 6 Protects Cells from Anoikis by Directly Phosphorylating Focal Adhesion Kinase and Activating AKT

  2012cited by this paper
• Brk/PTK6 Sustains Activated EGFR Signaling through Inhibiting EGFR Degradation and Transactivating EGFR

  2011cited by this paper
• Defining MAP3Kinases Required for MDA-MB-231 Cell Tumor Growth and Metastasis

  2011cited by this paper
• Disruption of the mouse protein tyrosine kinase 6 gene prevents STAT3 activation and confers resistance to azoxymethane.

  2011cited by this paper
• Mechanisms of HGF/Met Signaling to Brk and Sam68 in Breast Cancer Progression

  2011cited by this paper
• Protein-tyrosine Kinase 6 Promotes Peripheral Adhesion Complex Formation and Cell Migration by Phosphorylating p130 CRK-associated Substrate*

  2011cited by this paper
• The Alternative Splice Variant of Protein Tyrosine Kinase 6 Negatively Regulates Growth and Enhances PTK6-Mediated Inhibition of β-Catenin

  2011cited by this paper
• Integrative genomic profiling of human prostate cancer.

  2010cited by this paper
• EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

  2010cited by this paper
• Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells

  2010cited by this paper
• PTK6 Regulates IGF-1-Induced Anchorage-Independent Survival

  2010cited by this paper
• Cytoplasmic retention of protein tyrosine kinase 6 promotes growth of prostate tumor cells

  2010cited by this paper
• Brk/PTK6 signaling in normal and cancer cell models.

  2010cited by this paper
• Building a better understanding of the intracellular tyrosine kinase PTK6 - BRK by BRK.

  2010cited by this paper
• Protein Tyrosine Kinase 6 Directly Phosphorylates AKT and Promotes AKT Activation in Response to Epidermal Growth Factor

  2010cited by this paper
• Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models

  2010cited by this paper
• Identification of β-catenin as a target of the intracellular tyrosine kinase PTK6

  2010cited by this paper
• Differential trafficking of Src, Lyn, Yes and Fyn is specified by the state of palmitoylation in the SH4 domain

  2009cited by this paper
• Epithelial-mesenchymal transitions in development and disease.

  2009cited by this paper
• Akt regulates L-type Ca2+ channel activity by modulating Cavα1 protein stability

  2009cited by this paper
• Induction of protein tyrosine kinase 6 in mouse intestinal crypt epithelial cells promotes DNA damage-induced apoptosis.

  2009cited by this paper
• Oncogenic functions of PTK6 are enhanced by its targeting to plasma membrane but abolished by its targeting to nucleus.

  2009cited by this paper
• Akt regulates L-type Ca2+ channel activity by modulating Cavα1 protein stability

  2009cited by this paper
• Brk is coamplified with ErbB2 to promote proliferation in breast cancer

  2008cited by this paper
• Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer.

  2008cited by this paper
• Breast tumor kinase phosphorylates p190RhoGAP to regulate rho and ras and promote breast carcinoma growth, migration, and invasion.

  2008cited by this paper
• Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells.

  2007cited by this paper
• Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1

  2007cited by this paper
• Protein Tyrosine Kinase 6 Negatively Regulates Growth and Promotes Enterocyte Differentiation in the Small Intestine

  2006cited by this paper
• Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation

  2006cited by this paper
• Epithelial–mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways

  2005cited by this paper
• Interaction between Brk kinase and insulin receptor substrate-4

  2005cited by this paper
• Src SH3/2 domain-mediated peripheral accumulation of Src and phospho-myosin is linked to deregulation of E-cadherin and the epithelial-mesenchymal transition.

  2004cited by this paper
• Brk Activates Rac1 and Promotes Cell Migration and Invasion by Phosphorylating Paxillin

  2004cited by this paper
• Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition

  2004cited by this paper
• Pten Dose Dictates Cancer Progression in the Prostate

  2003cited by this paper
• Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells

  2003cited by this paper
• The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines.

  2003cited by this paper
• Regulation of the Nonreceptor Tyrosine Kinase Brk by Autophosphorylation and by Autoinhibition*

  2002cited by this paper
• Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling

  2002cited by this paper
• Expression of the BRK tyrosine kinase in mammary epithelial cells enhances the coupling of EGF signalling to PI 3-kinase and Akt, via erbB3 phosphorylation

  2000cited by this paper
• Aberrant E-cadherin and alpha-catenin expression in prostate cancer: correlation with patient survival.

  1997cited by this paper
• A role for the epithelial-cell-specific tyrosine kinase Sik during keratinocyte differentiation.

  1997cited by this paper
• Brk, a Breast Tumor-derived Non-receptor Protein-tyrosine Kinase, Sensitizes Mammary Epithelial Cells to Epidermal Growth Factor*

  1996cited by this paper
• Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer.

  1994cited by this paper
• Mutation of NH2-terminal glycine of p60src prevents both myristoylation and morphological transformation.

  1985cited by this paper

• A Perspective on Therapeutic Targeting Against Ubiquitin Ligases to Stabilize Tumor Suppressor Proteins

  2025cites this paper
• Development and validation of a kinase-related gene signature as a novel diagnostic and prognostic model for prostate cancer.

  2025cites this paper
• Discovery of novel 1H-pyrazolo[3,4-d]pyrimidine derivatives as BRK/PTK6 inhibitors.

  2025cites this paper
• Identification of immune-associated biomarker for predicting lung adenocarcinoma: bioinformatics analysis and experiment verification of PTK6

  2024cites this paper
• PTK6: An emerging biomarker for prognosis and immunotherapeutic response in clear cell renal carcinoma (KIRC)

  2024cites this paper
• Circular RNA hsa_circ_0001610 promotes prostate cancer progression by sponging miR-1324 and upregulating PTK6.

  2024cites this paper
• Therapeutic Potential of Protein Tyrosine Kinase 6 in Colorectal Cancer

  2023cites this paper
• PTK6 inhibits autophagy to promote uveal melanoma tumorigenesis by binding to SOCS3 and regulating mTOR phosphorylation

  2023cites this paper
• In Silico Screening of Multi-Domain Targeted Inhibitors for PTK6: A Strategy Integrating Drug Repurposing and Consensus Docking

  2023cites this paper
• Protein tyrosine kinase 6 regulates activation of SRC kinase

  2022cites this paper
• Epigenetic Deregulation of Protein Tyrosine Kinase 6 Promotes Carcinogenesis of Oral Squamous Cell Carcinoma

  2022cites this paper
• Interference of PTK6/GAB1 signaling inhibits cell proliferation, invasion, and migration of cervical cancer cells

  2022cites this paper
• Pharmacological targeting PTK6 inhibits the JAK2/STAT3 sustained stemness and reverses chemoresistance of colorectal cancer

  2021cites this paper
• Putting the BRK on breast cancer: From molecular target to therapeutics

  2021cites this paper
• Knockdown of microRNA-214-3p Promotes Tumor Growth and Epithelial-Mesenchymal Transition in Prostate Cancer

  2021cites this paper
• Global Histone H3 Lysine 4 Trimethylation (H3K4me3) Landscape Changes in Response to TGFβ

  2021cites this paper
• Protein tyrosine kinase 6 signaling in prostate cancer.

  2020influential citation
• An integrated autophagy-related gene signature predicts prognosis in human endometrial Cancer

  2020cites this paper
• Targeting protein tyrosine kinase 6 in cancer.

  2020influential citation
• MicroRNA-214 targets PTK6 to inhibit tumorigenic potential and increase drug sensitivity of prostate cancer cells

  2019cites this paper
• Vemurafenib Inhibits Active PTK6 in PTEN-null Prostate Tumor Cells

  2019cites this paper
• Decreased expression of protein tyrosine kinase 6 contributes to tumor progression and metastasis in laryngeal squamous cell carcinoma.

  2018cites this paper
• PTK6 Localized at the Plasma Membrane Promotes Cell Proliferation and MigratiOn Through Phosphorylation of Eps8

  2017cites this paper
• PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cells

  2017cites this paper
• PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer

  2017cites this paper
• Formulation of Nonionic Surfactant Vesicles (NISV) Prepared by Microfluidics for Therapeutic Delivery of siRNA into Cancer Cells.

  2017cites this paper
• PTK6 (protein tyrosine kinase 6)

  2017cites this paper
• PTK6 Inhibition Suppresses Metastases of Triple-Negative Breast Cancer via SNAIL-Dependent E-Cadherin Regulation.

  2016cites this paper
• PTK6 promotes hepatocellular carcinoma cell proliferation and invasion.

  2016cites this paper
• Kinase-Dependent and -Independent Roles for PTK6 in Colon Cancer

  2016influential citation
• MicroRNA-187, a downstream effector of TGFβ pathway, suppresses Smad-mediated epithelial-mesenchymal transition in colorectal cancer.

  2016cites this paper
• PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2+ breast cancer cells by inducing Bim

  2015cites this paper
• Protein tyrosine kinase 6 mediates TNFα-induced endothelial barrier dysfunction.

  2015cites this paper
• Tracing the footprints of the breast cancer oncogene BRK - Past till present.

  2015cites this paper
• Cancer-Associated Mutations in Breast Tumor Kinase/PTK6 Differentially Affect Enzyme Activity and Substrate Recognition.

  2015cites this paper
• Protein Tyrosine Kinase 6 Regulates UVB Induced Signaling and Tumorigenesis in Mouse Skin

  2015influential citation
• Genetic similarity between cancers and comorbid Mendelian diseases identifies candidate driver genes

  2015cites this paper
• PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors

  2014influential citation
• Epigenetic targeting of ovarian cancer stem cells.

  2014cites this paper
• The Role of Protein Tyrosine Kinase 6 in the Mammary Gland Epithelium and Breast Cancer

  2014cites this paper
• Marine natural products-inspired phenylmethylene hydantoins with potent in vitro and in vivo antitumor activities via suppression of Brk and FAK signaling.

  2014cites this paper
• PTK6 Promotes Cancer Migration and Invasion in Pancreatic Cancer Cells Dependent on ERK Signaling

  2014cites this paper
• Tumor and Stem Cell Biology Epigenetic Targeting of Ovarian Cancer Stem Cells

  2014cites this paper
• Non-viral nanocarriers for siRNA delivery in breast cancer.

  2014cites this paper
• Protein tyrosine kinase 6 regulates mammary gland tumorigenesis in mouse models

  2013cites this paper